Role of cervical cancer screening during prenatal checkups for infectious diseases: A retrospective, descriptive

Yasuyo Maruyama1, Akiko Sukegawa1,2, Hiromi Yoshida3

  • 1Obstetrics and Gynecology, Odawara Municipal Hospital, Odawara, Kanagawa, Japan.

Insights

Prenatal screening for cervical cytology is vital, especially in Japan, as few women undergo regular pre-pregnancy screening. This study highlights its crucial role in preventing cervical cancer during pregnancy.

Area of Science:

  • Obstetrics and Gynecology
  • Infectious Disease Screening
  • Oncology

Background:

  • Routine prenatal checkups offer opportunities for screening beyond infectious diseases.
  • Cervical cancer prevention strategies are crucial for maternal health.
  • Human papillomavirus (HPV) infection is a primary cause of cervical cancer.

Purpose of the Study:

  • To assess the status and role of cervical cytology screening during pregnancy.
  • To evaluate the impact of HPV and other infections on cervical cytology results in pregnant women.
  • To understand the prevalence of cervical abnormalities detected during prenatal care.

Main Methods:

  • Retrospective examination of medical records from 2014-2017.
  • Analysis of screening results for infectious diseases and cervical cancer in 3393 deliveries.
  • Review of cervical cytology data for 2641 women during pregnancy.

Main Results:

  • Only 18.8% of women had recent pre-pregnancy cervical cancer screening.
  • During pregnancy, 3.0% of women (79/2641) showed abnormal cervical cytology results.
  • Newly detected cervical intraepithelial neoplasia (CIN) grade ≥1 was found in 42 cases; no major adverse reactions reported.

Conclusions:

  • Prenatal cervical cytology screening plays a significant role in cervical cancer prevention in Japan.
  • Low rates of pre-pregnancy screening emphasize the importance of utilizing prenatal visits for cervical health assessment.
  • Screening for infectious diseases and cervical abnormalities during pregnancy is recommended.
Abstract